20 years of regulatory experience working for the SFDA and the Pharmaceutical industry. Successfully managed mega regulatory projects such as multinational mergers & acquisitions, the establishment of new pharma and medical device manufacturers, Tech Transfers/localisation, technical file development (eCTD, MDD/MDR TFA), in/out-licensing of portfolios, and others. Unique access abilities to the SFDA, MOH, MOHAP, and other GCC authorities. Managed joint projects with top pharma and MedTech companies such as: Pharma: Novartis, GSK, Astra Zeneca, MSD, Abbot, Amgen, and more. MedTech: PDI, SECA, SNIBE, ZOLL, Essilor, Quanta Systems, and more. Author and creator of new due diligence and gap analysis methods for products and entities. Advise with an innovative and visionary opinion in regulatory strategies (time, cost, & efficiency). Experienced with a wide range of RA projects and submission types as a firsthand implementor. High knowledge of regulations, RA intel, and industry dynamics. Excellent communication skills with global business offices and local commercial partners.